Podcast host Justin Prochnow along with GT colleagues Jim Prochnow and Michael Goodman discuss hot topics on the agenda in 2022. The trio starts by volleying a wide array of topics ranging from the upcoming end to the temporary rules on making hand sanitizers during COVID to increased scrutiny from the FTC on the use of endorsements and testimonials in social media to now mandatory USDA requirements for declaring bio-engineered ingredients. Other topics include an expected uptick in CBD regulation, renewed discussions of the exclusionary clause surrounding NAC and CBD, FDA regulation of test kits and testing labs, and, yes, plaintiff lawyer driven class action lawsuits. Listen in to hear where the GT regulatory team sees the spotlights shining so you are prepared to meet 2022 head on.